AI assistant
Sending…
Edesa Biotech, Inc. — Director's Dealing 2022
Mar 15, 2022
35006_dirs_2022-03-15_274512f7-16b4-4b1e-92a5-251da83a4a71.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2022-03-14
Reporting Person: Brooks Michael J (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-14 | Common Shares | P | 1250 | $2.7893 | Acquired | 16741 | Direct |
More from Edesa Biotech, Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Regulatory Filings
2026
Feb 24
Interim / Quarterly Report
2026
Feb 13